Nospharma joins District 3 Innovation

Nospharma was competitively selected to join the Launch & Grow program at District 3 Innovation, which comes with 2-years of individualized support to help us grow.

In addition to workshops for skill development, we are exposed to VC’s and angel investors and have access to the subject-matter experts that we need.

As part of our acceptance into the program, our CEO Anmol Nagpal, was awarded a Fellowship to work closely alongside the D3 team to help new life-science startups validate their business models.

A huge thank you to Margaret Bywater-Ekegärd, our coach at D3 and biggest supporter, who sees the massive impact Nospharma can make on the lives of people with severe forms of autism and intellectual disability.

Thank you also to Jean-David Begin, Edna Chosack, Rukmani Ramachandran, Pamela Champagne, Lloyd Bureau, and Anmol Trehan at D3 for the ongoing encouragement, feedback, and amazing workshops and content you deliver.

We’re thrilled to be part of the D3 ecosystem!

Previous
Previous

Nospharma & cureGRIN Foundation Join Forces with a $25k Partnership

Next
Next

Bowie lab awarded $150K to study NOS-01 therapy for SYNGAP1-related disorders